Alone or in combination with other pain management modalities, the use of opioids can be a mainstay of adequate analgesia. However, increased prescribing and availability of opioid medications correlate with overall medication abuse and misuse rates. Prescription drug nonmedical use is second only to marijuana as the most common form of newly initiated illicit drug use (Fig. 1). (1) Surveys among adolescent populations similarly support a high incidence of nonmedical opioid medication use. (1)(2) Nonmedical opioid use rates among 12-to 17-year-old children have stabilized (Fig. 2) , (3) but the overall prevalence of such inappropriate use may prompt pediatricians to consider decreasing opioid prescribing and potentially undertreat pain in an attempt to reduce the abuse of these medications. Pediatricians must be knowledgeable about the prevalence of pediatric nonmedical opioid use, its pattern, and appropriate prevention strategies. This article reviews the nonmedical use of prescription opioids in the pediatric population. The characteristics of such usage are incorporated into prevention, screening, and management strategies.
Introduction
Alone or in combination with other pain management modalities, the use of opioids can be a mainstay of adequate analgesia. However, increased prescribing and availability of opioid medications correlate with overall medication abuse and misuse rates. Prescription drug nonmedical use is second only to marijuana as the most common form of newly initiated illicit drug use (Fig. 1). (1) Surveys among adolescent populations similarly support a high incidence of nonmedical opioid medication use. (1)(2) Nonmedical opioid use rates among 12-to 17-year-old children have stabilized (Fig. 2) , (3) but the overall prevalence of such inappropriate use may prompt pediatricians to consider decreasing opioid prescribing and potentially undertreat pain in an attempt to reduce the abuse of these medications. Pediatricians must be knowledgeable about the prevalence of pediatric nonmedical opioid use, its pattern, and appropriate prevention strategies. This article reviews the nonmedical use of prescription opioids in the pediatric population. The characteristics of such usage are incorporated into prevention, screening, and management strategies.
Definitions
To appreciate the characteristics of opioid use, it is essential to understand basic nomenclature. Terminology describing the pharmacology and clinical diagnoses associated with opioids and their nonmedical use frequently is used inconsistently and incorrectly, resulting in stigmatization and undertreatment of pain. Table 1 reviews definitions for opiate, narcotic, and opioid and selected opioid use and abuse definitions. Opioid is the preferred definition for referencing this class of analgesic medications. (4) (5) report lifetime and past-year nonmedical opioid usage, respectively. (12) Because medical and nonmedical opioid use overlap, nonmedical use behaviors may be masked and make diagnosis difficult. Ranges of 2.7% to 3.8% (2)(3) of surveyed children, ages 12 to 17 years, engage in past-month nonmedical opioid use, comprising the second highest population group using opioids for nonmedical reasons (Fig. 2) . A higher percentage of pediatric respondents (7% to 12%) identify themselves as past-year nonmedical opioid users. (2)(8)(9)(10) Lifetime nonmedical opioid prevalence is highest, ranging from almost 10% to 18% of all children, ages 12 to 18 years. (2)(11)(12) (13) However, these increasing prevalence patterns over time do not equate to consistent usage; more than 50% of surveyed 12th graders report fewer than five occasions of lifetime nonmedical opioid use. (2) Similarly, 82% of respondents from a different study reported less than weekly or no past-year nonmedical opioid use. (13) The previously cited prevalence and usage rates suggest that nonmedical opioid use is inconsistent, yet increases over a lifetime. Anticipatory counseling regarding nonmedical opioid use, therefore, should focus both at regular intervals and during other identified "high-risk" periods through adolescence.
Compared with prescription opioids, lifetime prevalence of heroin abuse is less common, ranging between 1.2% and 1.4% among adolescents. (2) Prevalence of illicit, designer fentanyl analogs (china white, Mexican brown, tango & cash) usage among children is unknown.
Demographics
Certain demographic characteristics listed in Table 2 are significantly associated with pediatric nonmedical opioid use and can assist the pediatrician in screening.
Clinical Aspects Use Motivations
Sixty-nine percent of pediatric respondents report pain control for conditions such as migraine headaches or menstrual cramps as the sole reason to engage in nonmedical opioid use. (8) Most pediatric nonmedical opioid use, therefore, may more appropriately be classified as self-medication or opioid misuse. This misuse pattern explains why most pediatric nonmedical users identify themselves as both medical and nonmedical users. Nonmedical users report taking opioids to aid sleep (15.7%) as the second most common motive, (8) which possibly indicates a transitional motivation to more concerning, abusive behaviors. Only a minority (11%) of pediatric nonmedical opioid users endorse using opioids solely to "get high." (8) Similarly, fewer than 10% of nonmedical opioid users cite motivations such as "helps decrease anxiety, counteracts other drugs, safer than street drugs, experimenta- 
Diversion Behaviors
Opioid diversion among pediatric nonmedical users is common and follows sex and age associations. After allergy medications, opioid medications are the second most commonly loaned and borrowed prescription medications by children aged 12 to 17 years (14) and comprise one of the most commonly diverted class of scheduled medications. (10) Twenty-five percent of older children report giving away their opioid prescriptions, and 10% report trading opioid medications. (10) Recent medical users are especially likely to contribute to diversion; 64% report being approached to give, trade, or loan opioid medications within the past year of receiving an opioid prescription. (10) Most pediatric nonmedical opioid users obtain opioid medications for free from well-known sources, such as family (34%) and friends (17%). (12) Girls are more likely than boys to divert pain medications, and older children are more likely to divert opioids than younger children. (14) One consequence of such diversion behaviors is that 75% of children report borrowing medications in place of making an appointment with a health-care practitioner (HCP). (14) Moreover, 32% still sought a HCP after taking borrowed medications, but 41% did not inform the HCP about borrowing the medication during the 
Psychiatric Terms
• Medical Use: The compliant use of a medication at the dose, frequency, treatment interval, and purpose intended by the prescriber. visit. (14) Patients and families must be reminded of the inherent medical risks, potential masking of symptoms, and inappropriate delay in seeking timely treatment associated with opioid diversion.
Abuse and Dependence Associations
Although most pediatric nonmedical opioid users report pain relief as the reason for opioid use, a significant minority endorse more concerning abuse and addiction motives. Pediatric nonmedical opioid use accordingly demonstrates a higher prevalence of opioid abuse and dependence diagnoses. Thirty-five percent of pastyear nonmedical users meet criteria for abuse, subthreshold dependence, or dependence diagnoses versus 1.1% of a baseline population (9) , and stands in contrast to the percentage of pediatric nonmedical users who report pain control as the sole motivation (69%) and are at decreased risk for substance abuse. (8) 
Education
• Nonmedical opioid prevalence is higher among school dropouts.
• Children who have no college plans report a higher prevalence of nonmedical opioid use compared to those who plan to attend college.
Health Indicators
• Children who have higher nonmedical opioid use prevalence rates report the following: -Perceived poor-to-fair health.
-A past-year hospitalization.
-Three or more past-year emergency department visits. Nonmedical opioid use also correlates positively with increased substance abuse beyond opioids, such as higher alcohol, marijuana, and inhalant use at younger ages, compared with nonusers. Nonmedical opioid users are more than eight times more likely than nonusers to engage in other underage and illicit drug use (medical users: odds ratioϭ1.5). (12) Nonmedical users are also more likely to use multiple substances. (11)(12)
Clinical Presentation
Opioids interact with 1 , 2 , , and ␦ opioid receptors predominantly located in nervous and gastrointestinal tissues. The 1 receptor is notably responsible for both analgesia and dependence symptoms. The receptor also produces analgesia as well as sedation. The 2 receptor produces common adverse effects. Most opioid medications affect several receptors, acting as agonists, antagonists, or mixed agonists/antagonists.
Opioids overall increase parasympathetic and decrease sympathetic activity. Table 4 lists select clinical symptoms and signs observed in opioid ingestion and overdose. Symptom severity is generally dose-and tolerancerelated. (16) Most prescription opioids are taken orally (crushed or whole) and produce symptoms for 3 to 6 hours, with the exception of methadone, whose effects may last as long as 48 hours. Heroin acts within shorter time periods, producing euphoria in less than 5 to 30 minutes (intravenous and inhaled routes, respectively), with effects generally lasting less than 1 hour. Designer fentanyl analogs are taken for effects and by routes similar to heroin, yet are significantly more potent. Meperidine analogs have been known to cause irreversible Parkinson-like symptoms.
The combination of coma, respiratory depression, and pinpoint pupils suggests opioid overdose. Patients commonly are profoundly stuporous or comatose, prompting associated airway and aspiration concerns. Adverse respiratory and neurologic symptoms are the most life-threatening consequences that may be observed up to 24 hours after overdose. Central respiratory depression causes decreased respiratory rate and tidal volume, which leads to cerebral hypoxia/ischemia. Noncardiogenic pulmonary edema also may result, manifesting as crackles on auscultation and pink, foamy secretions. Common cardiovascular effects include 
Prevention
Prevention of pediatric nonmedical opioid use encompasses both primary and secondary prevention strategies. Pediatricians are in a unique position to recognize substance abuse in their patients. A child's selection of drug use is related to its perceived risk, social approval, and availability. Accordingly, primary preventive strategies should focus on the following factors and be incorporated into anticipatory guidance.
Risk Education
The riskier a medication is perceived to be, the less likely it will be used nonmedically or abused. Children perceive prescription opioids to be safer than heroin and illicit/ street drugs, despite the fact that their nonmedical use can pose equally dangerous consequences. As part of routine anticipatory education, clinicians should dispel any misperceptions to both patients and family members that prescription opioid medications are safer than other illicit drugs when taken at different dosages, frequencies, or intents than prescribed. Pediatricians must incorporate this same discussion into their opioid prescribing instructions because even medical opioid users demonstrate potential risk for nonmedical use. When prescribing opioids, pediatricians also should encourage patients to maintain open communication and return for reevaluation if pain persists, rather than engage in selfmedication for pain, medical misuse, or diversion behaviors.
Accessibility
In addition to risk education, pediatricians should incorporate accessibility issues into their guidance. Wellintended patients and family members must be reminded not to divert prescription opioids to each other or friends. Diversion discussions should take place when initially prescribing opioids and at subsequent visits during opioid use because this is a relatively high-risk period for nonmedical opioid use and diversion. Pediatricians should advocate and encourage parents to store and lock opioid medications securely to prevent easy access. Patients and families also should properly dispose of unused opioid prescriptions. Pediatricians can provide patients and families information about local community prescription medication disposal programs offered through police stations or hospitals at regular intervals. The Office of National Drug Control Policy website (see Resources) offers further guidelines and resources regarding prescription drug disposal because discarding medications in the toilet is no longer appropriate for most medications.
Parental Factors
In coordination with clinician counseling, parental involvement serves as a protective factor preventing nonmedical opioid use. Parents may not perceive the prevalence and risks of prescription nonmedical opioid use. Pediatricians should educate parents regarding these risks and encourage parents to talk to their children about nonmedical prescription opioid use at an early age, before behaviors are less likely to have begun. This discussion should also occur during periods of prescription opioid medical use. Although not opioid-specific, children who report that their parents strongly disapprove of their using substances (alcohol, marijuana, or cigarettes) are less likely to use these substances than respondents who believe their parents would somewhat disapprove or neither approve nor disapprove.
(1) Similarly, past-month illicit drug use is lower among children who report that their parents always or sometimes engage in monitoring behaviors (eg, inquiring of friends and activities) than among those whose parents seldom or never engage in such behaviors. (1) As part of this monitoring effort, parents should be encouraged to regulate proper prescription opioid use closely. Older children may be assumed to be independently taking medications correctly and may not always receive such oversight. Positive reinforcement is equally important in these discussions because perceived higher levels of parents offering positive feedback for desired behaviors correlate with decreased opioid misuse. The National Family Partnership (18) and The Partnership for a Drug-Free America ® (19) are nonprofit organizations focused on youth drug prevention, education, and advocacy that offer educational resources, medication inventory cards, and drug abuse prevention pledges.
Schools
When prescription opioids must be taken at school, pediatricians should collaborate with their community's school districts to create policies directing how medication should be accessed, dispensed, and monitored to minimize potential nonmedical use and diversion at school. School environments significantly influence substance abuse behaviors. (20) Recommendations are available regarding medication administration at schools. substance abuse opioids (21) Such policies should include and address the following: (21) 1. The requirement for a written medication form signed by the prescriber and parents that fully explains the medication's dosage and intent.
2. Maintenance of school medication dispensing records.
3. Prohibition of students self-carrying controlled substances.
4. Controlled substance storage in a double-locked, secure location.
In addition to participating in school medication administration policies, pediatricians may also collaborate with schools and community centers on community drug prevention programs. Effective programs are known to focus on problem-solving skills, self-esteem, media influences, stress issues, and "life skills training" (eg, teaching skills to confront specific problems/scenarios). (20) Pediatricians not only have familiarity with the social and developmental challenges that older children encounter, but they also have medical knowledge of opioid medications and their associated risks. Pediatrician participation in such programs as an expert resource is beneficial.
Screening
In conjunction with primary prevention strategies, clinicians must also be comfortable with secondary prevention measures. Secondary prevention involves early recognition and screening of problematic behaviors before they escalate. Most pediatric nonmedical prescription medication users (75%) do not inform their physicians of their nonmedical use. (14) Knowledge of nonmedical opioid use risks and demographics (eg, sex, age, race, health status, and known substance abuse history) assists clinicians in identifying potentially at-risk individuals and helps to focus screening efforts. Given the association between medical and nonmedical opioid use, it is important that pediatricians proactively question pediatric medical opioid users about potential nonmedical opioid misuse. Pediatricians similarly should specifically ask about nonmedical opioid use, prescription medication misuse, and pain self-medication practices as part of their more generalized drug screening efforts because these practices may not necessarily be considered risky or problematic by parents or patients.
Formalized clinical screening tools beyond clinician inquiry also may be employed. Several opioid-specific abuse screening tests have been tested among adults with promising validity, but none has been tested yet in the pediatric population. A CRAFFT screening test (Table  5) identifies teenage substance abuse beyond clinician inquiry alone. (22)(23) CRAFFT is a mnemonic representing key items in each question (Car, Relax, Alone, Forget, Friends, Trouble). Patients should be counseled that "drugs" in CRAFFT questioning refer to both prescription and illicit substances because they may interpret "drugs" as only illicit street drugs.
Because nonmedical opioid use is associated with substance abuse and dependency for a minority of nonmedical users, clinicians should be able to screen for these specific conditions when initial screening is positive. Further questioning should focus on identifying hazardous use, role interference, withdrawal, giving up activities, and continued opioid use despite having physical or psychological problems, all of which are significantly associated with opioid abuse and dependence (Table 3) .
State prescription drug monitoring programs (24) have been shown to be beneficial in identifying patients who receive several opioid prescriptions from multiple HCPs. Most states offer this program; physician registration eligibility and information offered depend on individual programs. Further information regarding these programs, including state-specific programs and contact information, may be found on the Drug Enforcement Agency (24) and National Association of State Controlled Substances Authorities (25) websites.
Routine laboratory testing is not recommended to screen for unsuspected opioid use. (26) Drug testing is appropriate when increased clinical suspicion exists and should follow patient consent, confidentiality, and tamper-prevention recommendations. Because drug 
Management of Opioid Overdose
Identification of the overdosed opioid, when possible; its expected duration of action; associated risk factors; and the anticipated level of appropriate respiratory, cardiovascular, and neurologic care should be considered.
Primary management of opioid overdose should focus on respiratory, cardiac, and neurologic stabilization and reversal of signs. Any airway and breathing compromise should be assessed and treated appropriately with supplemental oxygen, pulse oximetry monitoring, arterial blood gas measurement, bag-mask ventilation, and tracheal intubation. Comatose patients who have impaired gag reflexes and are at risk for aspiration should be intubated and ventilated. Positive-pressure ventilation assists in reversing noncardiogenic pulmonary edema. Circulation generally improves after adequate ventilation restoration, but symptomatic hypotension, bradycardia, and arrhythmias require management found in resuscitation guidelines and resources. (27) An opioid antagonist, such as naloxone, should be administered soon after or during airway and circulation stabilization.
Naloxone is a derivative of oxymorphone and possesses a high binding affinity and antagonistic action at , , ␦, and receptors. Naloxone is the preferred agent for pediatric opioid overdose and can be administered via various parenteral routes. Recommended naloxone dosing for acute opioid overdose in older children weighing 20 kg or greater is 2 mg intravenously every 2 to 5 minutes, as necessary, until symptom reversal (maximum cumulative dose, 10 mg). Dosing should be reduced to 0.2 to 0.4 mg in older children suspected of having opioid dependence or addiction to minimize withdrawal symptoms and seizures. The onset of action for naloxone is within 1 minute when administered intravenously and generally lasts for 1 hour. Naloxone possesses a shorter duration of action than most opioids, and additional doses may be required. Continuous naloxone infusions may also be administered in such circumstances, (28) with dosing recommendations extending beyond this review's scope.
Nalmefene is a secondary opioid antagonist option that possesses a longer duration of action than naloxone. Limited research demonstrates nalmefene to be a safe and effective opioid reversal agent specifically for controlled sedation procedures in children, (29) but it has a less well-established role for acute opioid overdose in the pediatric population. Most authorities, therefore, regard nalmefene as a secondary option to naloxone for acute opioid overdose.
Additional acute opioid overdose management may include activated charcoal (1 g/kg) and gastric lavage for acute opioid overdoses known to occur less than 2 hours before presentation. Urinary output should be monitored. If urinary retention is a concern, bladder ultrasonography and catheterization should be considered. Pruritus can be managed with histamine-1 blockers such as diphenhydramine. Nausea and emesis may be treated with antiemetics such as ondansetron or metoclopramide. Consultations with a pediatric psychiatrist as well as addiction, pain, and adolescent specialists are warranted.
